LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Benede, Ntombi"
  2. AU="Keller, Mark P"

Search results

Result 1 - 10 of total 19

Search options

  1. Article: Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb.

    Naicker, Nikita / Rodel, Hylton / Perumal, Rubeshan / Ganga, Yashica / Bernstein, Mallory / Benede, Ntombi / Abdool Karim, Salim / Padayacthi, Nesri / Sigal, Alex / Naidoo, Kogieleum

    Infection and drug resistance

    2023  Volume 16, Page(s) 3629–3638

    Abstract: Introduction: Current TB treatment regimens are pathogen-directed and can be severely compromised by the development of drug resistance. Metformin has been proposed as an adjunctive therapy for TB, however relatively little is known about how metformin ... ...

    Abstract Introduction: Current TB treatment regimens are pathogen-directed and can be severely compromised by the development of drug resistance. Metformin has been proposed as an adjunctive therapy for TB, however relatively little is known about how metformin modulates the cellular interaction between Mtb and macrophages. We aimed to characterize how metformin modulates Mtb growth within macrophages.
    Methods: We utilized live cell tracking through time-lapse microscopy to better understand the biological effect of metformin in response to Mtb infection. Furthermore, the potent first-line anti-TB drug, isoniazid, was used as a comparator and as a companion drug.
    Results: Metformin caused a 14.2-fold decrease in Mtb growth compared to the untreated control. Metformin combined with isoniazid controlled Mtb growth is slightly better than isoniazid alone. Metformin demonstrated the ability to regulate the cytokine and chemokine response over a 72 hour period, better than isoniazid only.
    Conclusion: We provide novel evidence that metformin controls mycobacterial growth by increasing host cell viability, and a direct and independent pro-inflammatory response to Mtb. Understanding the impact of metformin on Mtb growth within macrophages will advance our current knowledge on metformin as an adjunctive therapy, providing a new host-directed approach to TB treatment.
    Language English
    Publishing date 2023-06-07
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2494856-1
    ISSN 1178-6973
    ISSN 1178-6973
    DOI 10.2147/IDR.S401403
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity.

    Benede, Ntombi S B / Tincho, Marius B / Walters, Avril / Subbiah, Vennesa / Ngomti, Amkele / Baguma, Richard / Butters, Claire / Mennen, Mathilda / Skelem, Sango / Adriaanse, Marguerite / van Graan, Strauss / Balla, Sashkia R / Moyo-Gwete, Thandeka / Moore, Penny L / Botha, Maresa / Workman, Lesley / Zar, Heather J / Ntusi, Ntobeko A B / Zühlke, Liesl /
    Webb, Kate / Riou, Catherine / Burgers, Wendy A / Keeton, Roanne S

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in 71 unvaccinated asymptomatic South ... ...

    Abstract SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in 71 unvaccinated asymptomatic South African children who were seropositive or seronegative for SARS-CoV-2. SARS-CoV-2-specific CD4+ T cell responses were detectable in 83% of seropositive and 60% of seronegative children. Although the magnitude of the CD4+ T cell response did not differ significantly between the two groups, their functional profiles were distinct, with SARS-CoV-2 seropositive children exhibiting a higher proportion of polyfunctional T cells compared to their seronegative counterparts. The frequency of SARS-CoV-2-specific CD4+ T cells in seronegative children was associated with the endemic human coronavirus (HCoV) HKU1 IgG response. Overall, the presence of SARS-CoV-2-responding T cells in seronegative children may result from cross-reactivity to endemic coronaviruses and could contribute to the relative protection from disease observed in SARS-CoV-2-infected children.
    Language English
    Publishing date 2023-05-23
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.05.16.23290059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Impact of SARS-CoV-2 exposure history on the T cell and IgG response.

    Keeton, Roanne / Tincho, Marius B / Suzuki, Akiko / Benede, Ntombi / Ngomti, Amkele / Baguma, Richard / Chauke, Masego V / Mennen, Mathilda / Skelem, Sango / Adriaanse, Marguerite / Grifoni, Alba / Weiskopf, Daniela / Sette, Alessandro / Bekker, Linda-Gail / Gray, Glenda / Ntusi, Ntobeko A B / Burgers, Wendy A / Riou, Catherine

    Cell reports. Medicine

    2022  Volume 4, Issue 1, Page(s) 100898

    Abstract: Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures, from infection or vaccination, can potently boost spike antibody responses. Less is known about the impact of repeated exposures on T cell responses. Here, we compare the ... ...

    Abstract Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures, from infection or vaccination, can potently boost spike antibody responses. Less is known about the impact of repeated exposures on T cell responses. Here, we compare the prevalence and frequency of peripheral SARS-CoV-2-specific T cell and immunoglobulin G (IgG) responses in 190 individuals with complex SARS-CoV-2 exposure histories. As expected, an increasing number of SARS-CoV-2 spike exposures significantly enhances the magnitude of IgG responses, while repeated exposures improve the number of T cell responders but have less impact on SARS-CoV-2 spike-specific T cell frequencies in the circulation. Moreover, we find that the number and nature of exposures (rather than the order of infection and vaccination) shape the spike immune response, with spike-specific CD4 T cells displaying a greater polyfunctional potential following hybrid immunity compared with vaccination only. Characterizing adaptive immunity from an evolving viral and immunological landscape may inform vaccine strategies to elicit optimal immunity as the pandemic progress.
    MeSH term(s) Humans ; Antibody Formation ; CD4-Positive T-Lymphocytes ; COVID-19/epidemiology ; Immunoglobulin G ; SARS-CoV-2 ; T-Lymphocytes
    Chemical Substances Immunoglobulin G
    Language English
    Publishing date 2022-12-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ISSN 2666-3791
    ISSN (online) 2666-3791
    DOI 10.1016/j.xcrm.2022.100898
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.

    Krause, Robert G E / Moyo-Gwete, Thandeka / Richardson, Simone I / Makhado, Zanele / Manamela, Nelia P / Hermanus, Tandile / Mkhize, Nonhlanhla N / Keeton, Roanne / Benede, Ntombi / Mennen, Mathilda / Skelem, Sango / Karim, Farina / Khan, Khadija / Riou, Catherine / Ntusi, Ntobeko A B / Goga, Ameena / Gray, Glenda / Hanekom, Willem / Garrett, Nigel /
    Bekker, Linda-Gail / Groll, Andreas / Sigal, Alex / Moore, Penny L / Burgers, Wendy A / Leslie, Alasdair

    NPJ vaccines

    2023  Volume 8, Issue 1, Page(s) 119

    Abstract: Neutralizing antibodies strongly correlate with protection for COVID-19 vaccines, but the corresponding memory B cells that form to protect against future infection are relatively understudied. Here we examine the effect of prior SARS-CoV-2 infection on ... ...

    Abstract Neutralizing antibodies strongly correlate with protection for COVID-19 vaccines, but the corresponding memory B cells that form to protect against future infection are relatively understudied. Here we examine the effect of prior SARS-CoV-2 infection on the magnitude and phenotype of the memory B cell response to single dose Johnson and Johnson (Ad26.COV2.S) vaccination in South African health care workers. Participants were either naïve to SARS-CoV-2 or had been infected before vaccination. SARS-CoV-2-specific memory B-cells expand in response to Ad26.COV2.S and are maintained for the study duration (84 days) in all individuals. However, prior infection is associated with a greater frequency of these cells, a significant reduction in expression of the germinal center chemokine receptor CXCR5, and increased class switching. These B cell features correlated with neutralization and antibody-dependent cytotoxicity (ADCC) activity, and with the frequency of SARS-CoV-2 specific circulating T follicular helper cells (cTfh). Vaccination-induced effective neutralization of the D614G variant in both infected and naïve participants but boosted neutralizing antibodies against the Beta and Omicron variants only in participants with prior infection. In addition, the SARS-CoV-2 specific CD8+ T cell response correlated with increased memory B cell expression of the lung-homing receptor CXCR3, which was sustained in the previously infected group. Finally, although vaccination achieved equivalent B cell activation regardless of infection history, it was negatively impacted by age. These data show that phenotyping the response to vaccination can provide insight into the impact of prior infection on memory B cell homing, CSM, cTfh, and neutralization activity. These data can provide early signals to inform studies of vaccine boosting, durability, and co-morbidities.
    Language English
    Publishing date 2023-08-12
    Publishing country England
    Document type Journal Article
    ISSN 2059-0105
    ISSN (online) 2059-0105
    DOI 10.1038/s41541-023-00724-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.

    Moyo-Gwete, Thandeka / Richardson, Simone I / Keeton, Roanne / Hermanus, Tandile / Spencer, Holly / Manamela, Nelia P / Ayres, Frances / Makhado, Zanele / Motlou, Thopisang / Tincho, Marius B / Benede, Ntombi / Ngomti, Amkele / Baguma, Richard / Chauke, Masego V / Mennen, Mathilda / Adriaanse, Marguerite / Skelem, Sango / Goga, Ameena / Garrett, Nigel /
    Bekker, Linda-Gail / Gray, Glenda / Ntusi, Ntobeko A B / Riou, Catherine / Burgers, Wendy A / Moore, Penny L

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26 ... ...

    Abstract The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26.COV2.S vaccine and a further one month after they received an Ad26.COV2.S booster dose. We assessed longitudinal spike-specific antibody and T cell responses in individuals who had never had SARS-CoV-2 infection, compared to those who were infected with either the D614G or Beta variants prior to vaccination. Antibody and T cell responses elicited by the primary dose were durable against several variants of concern over the 6 month follow-up period, regardless of infection history. However, at 6 months after first vaccination, antibody binding, neutralization and ADCC were as much as 33-fold higher in individuals with hybrid immunity compared to those with no prior infection. Antibody cross-reactivity profiles of the previously infected groups were similar at 6 months, unlike at earlier time points suggesting that the effect of immune imprinting diminishes by 6 months. Importantly, an Ad26.COV2.S booster dose increased the magnitude of the antibody response in individuals with no prior infection to similar levels as those with previous infection. The magnitude of spike T cell responses and proportion of T cell responders remained stable after homologous boosting, concomitant with a significant increase in long-lived early differentiated CD4 memory T cells. Thus, these data highlight that multiple antigen exposures, whether through infection and vaccination or vaccination alone, result in similar boosts after Ad26.COV2.S vaccination.
    Language English
    Publishing date 2023-03-15
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.03.15.23287288
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.

    Moyo-Gwete, Thandeka / Richardson, Simone I / Keeton, Roanne / Hermanus, Tandile / Spencer, Holly / Manamela, Nelia P / Ayres, Frances / Makhado, Zanele / Motlou, Thopisang / Tincho, Marius B / Benede, Ntombi / Ngomti, Amkele / Baguma, Richard / Chauke, Masego V / Mennen, Mathilda / Adriaanse, Marguerite / Skelem, Sango / Goga, Ameena / Garrett, Nigel /
    Bekker, Linda-Gail / Gray, Glenda / Ntusi, Ntobeko A B / Riou, Catherine / Burgers, Wendy A / Moore, Penny L

    PLoS pathogens

    2023  Volume 19, Issue 11, Page(s) e1011772

    Abstract: The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26 ... ...

    Abstract The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26.COV2.S vaccine and a further one month after they received an Ad26.COV2.S booster dose. We assessed longitudinal spike-specific antibody and T cell responses in individuals who had never had SARS-CoV-2 infection, compared to those who were infected with either the D614G or Beta variants prior to vaccination. Antibody and T cell responses elicited by the primary dose were durable against several variants of concern over the 6 month follow-up period, regardless of infection history. However, at 6 months after first vaccination, antibody binding, neutralization and ADCC were as much as 59-fold higher in individuals with hybrid immunity compared to those with no prior infection. Antibody cross-reactivity profiles of the previously infected groups were similar at 6 months, unlike at earlier time points, suggesting that the effect of immune imprinting diminishes by 6 months. Importantly, an Ad26.COV2.S booster dose increased the magnitude of the antibody response in individuals with no prior infection to similar levels as those with previous infection. The magnitude of spike T cell responses and proportion of T cell responders remained stable after homologous boosting, concomitant with a significant increase in long-lived early differentiated CD4 memory T cells. Thus, these data highlight that multiple antigen exposures, whether through infection and vaccination or vaccination alone, result in similar boosts after Ad26.COV2.S vaccination.
    MeSH term(s) Humans ; Ad26COVS1 ; COVID-19/prevention & control ; SARS-CoV-2 ; Antibodies ; Vaccination ; Adaptive Immunity ; Antibodies, Viral ; Antibodies, Neutralizing ; Immunity, Humoral
    Chemical Substances Ad26COVS1 (JT2NS6183B) ; Antibodies ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-11-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1011772
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response.

    Butters, Claire / Benede, Ntombi / Moyo-Gwete, Thandeka / Richardson, Simone I / Rohlwink, Ursula / Shey, Muki / Ayres, Frances / Manamela, Nelia P / Makhado, Zanele / Balla, Sashkia R / Madzivhandila, Mashudu / Ngomti, Amkele / Baguma, Richard / Facey-Thomas, Heidi / Spracklen, Timothy F / Day, Jonathan / van der Ross, Hamza / Riou, Catherine / Burgers, Wendy A /
    Scott, Christiaan / Zühlke, Liesl / Moore, Penny L / Keeton, Roanne S / Webb, Kate

    Clinical immunology (Orlando, Fla.)

    2023  Volume 259, Page(s) 109877

    Abstract: Multisystem inflammatory syndrome in children (MIS-C) is a severe, hyperinflammatory disease that occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The underlying immune pathology of MIS-C is incompletely understood, ... ...

    Abstract Multisystem inflammatory syndrome in children (MIS-C) is a severe, hyperinflammatory disease that occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The underlying immune pathology of MIS-C is incompletely understood, with limited data comparing MIS-C to clinically similar paediatric febrile diseases at presentation. SARS-CoV-2-specific T cell responses have not been compared in these groups to assess whether there is a T cell profile unique to MIS-C. In this study, we measured inflammatory cytokine concentration and SARS-CoV-2-specific humoral immunity and T cell responses in children with fever and suspected MIS-C at presentation (n = 83) where MIS-C was ultimately confirmed (n = 58) or another diagnosis was made (n = 25) and healthy children (n = 91). Children with confirmed MIS-C exhibited distinctly elevated serum IL-10, IL-6, and CRP at presentation. No differences were detected in SARS-CoV-2 spike IgG serum concentration, neutralisation capacity, antibody dependant cellular phagocytosis, antibody dependant cellular cytotoxicity or SARS-CoV-2-specific T cell frequency between the groups. Healthy SARS-CoV-2 seropositive children had a higher proportion of polyfunctional SARS-CoV-2-specific CD4+ T cells compared to children with MIS-C and those with other inflammatory or infectious diagnoses, who both presented a largely monofunctional SARS-CoV-2-specific CD4+ T cell profile. Treatment with steroids and/or intravenous immunoglobulins resulted in rapid reduction of inflammatory cytokines but did not affect the SARS-CoV-2-specific IgG or CD4+ T cell responses in MIS-C. In these data, MIS-C had a unique cytokine profile but not a unique SARS-CoV-2 specific humoral or T cell cytokine response.
    MeSH term(s) Humans ; Child ; COVID-19 ; SARS-CoV-2 ; Cytokines ; Immunoglobulin G ; Fever ; Antibodies, Viral ; Connective Tissue Diseases ; Systemic Inflammatory Response Syndrome
    Chemical Substances Cytokines ; Immunoglobulin G ; Antibodies, Viral
    Language English
    Publishing date 2023-12-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2023.109877
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity.

    Benede, Ntombi / Tincho, Marius B / Walters, Avril / Subbiah, Vennesa / Ngomti, Amkele / Baguma, Richard / Butters, Claire / Hahnle, Lina / Mennen, Mathilda / Skelem, Sango / Adriaanse, Marguerite / Facey-Thomas, Heidi / Scott, Christiaan / Day, Jonathan / Spracklen, Timothy F / van Graan, Strauss / Balla, Sashkia R / Moyo-Gwete, Thandeka / Moore, Penny L /
    MacGinty, Rae / Botha, Maresa / Workman, Lesley / Johnson, Marina / Goldblatt, David / Zar, Heather J / Ntusi, Ntobeko A B / Zühlke, Liesl / Webb, Kate / Riou, Catherine / Burgers, Wendy A / Keeton, Roanne S

    iScience

    2023  Volume 27, Issue 1, Page(s) 108728

    Abstract: SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on SARS-CoV-2 antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in 71 unvaccinated asymptomatic ... ...

    Abstract SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on SARS-CoV-2 antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in 71 unvaccinated asymptomatic South African children who were seropositive or seronegative for SARS-CoV-2. SARS-CoV-2-specific CD4
    Language English
    Publishing date 2023-12-14
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.108728
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

    Moyo-Gwete, Thandeka / Richardson, Simone I / Keeton, Roanne / Hermanus, Tandile / Spencer, Holly / Manamela, Nelia P / Ayres, Frances / Makhado, Zanele / Motlou, Thopisang / Tincho, Marius B / Benede, Ntombi / Ngomti, Amkele / Baguma, Richard / Chauke, Masego V / Mennen, Mathilda / Adriaanse, Marguerite / Skelem, Sango / Goga, Ameena / Garrett, Nigel /
    Bekker, Linda-Gail / Gray, Glenda / Ntusi, Ntobeko A.B / Riou, Catherine / Burgers, Wendy A / Moore, Penny L

    medRxiv

    Abstract: The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26 ... ...

    Abstract The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26.COV2.S vaccine and a further one month after they received an Ad26.COV2.S booster dose. We assessed longitudinal spike-specific antibody and T cell responses in individuals who had never had SARS-CoV-2 infection, compared to those who were infected with either the D614G or Beta variants prior to vaccination. Antibody and T cell responses elicited by the primary dose were durable against several variants of concern over the 6 month follow-up period, regardless of infection history. However, at 6 months after first vaccination, antibody binding, neutralization and ADCC were as much as 33-fold higher in individuals with hybrid immunity compared to those with no prior infection. Antibody cross-reactivity profiles of the previously infected groups were similar at 6 months, unlike at earlier time points suggesting that the effect of immune imprinting diminishes by 6 months. Importantly, an Ad26.COV2.S booster dose increased the magnitude of the antibody response in individuals with no prior infection to similar levels as those with previous infection. The magnitude of spike T cell responses and proportion of T cell responders remained stable after homologous boosting, concomitant with a significant increase in long-lived early differentiated CD4 memory T cells. Thus, these data highlight that multiple antigen exposures, whether through infection and vaccination or vaccination alone, result in similar boosts after Ad26.COV2.S vaccination.
    Keywords covid19
    Language English
    Publishing date 2023-03-15
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.03.15.23287288
    Database COVID19

    Kategorien

  10. Article ; Online: Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity

    Benede, Ntombi S. B. / Tincho, Marius B. / Walters, Avril / Subbiah, Vennesa / Ngomti, Amkele / Baguma, Richard / Butters, Claire / Mennen, Mathilda / Skelem, Sango / Adriaanse, Marguerite / van Graan, Strauss / Balla, Sashkia R. / Moyo-Gwete, Thandeka / Moore, Penny L. / Botha, Maresa / Workman, Lesley / Zar, Heather J. / Ntusi, Ntobeko A. B. / Zühlke, Liesl /
    Webb, Kate / Riou, Catherine / Burgers, Wendy A. / Keeton, Roanne S.

    medRxiv

    Abstract: SUMMARY SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in 71 unvaccinated asymptomatic ... ...

    Abstract SUMMARY SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in 71 unvaccinated asymptomatic South African children who were seropositive or seronegative for SARS-CoV-2. SARS-CoV-2-specific CD4+ T cell responses were detectable in 83% of seropositive and 60% of seronegative children. Although the magnitude of the CD4+ T cell response did not differ significantly between the two groups, their functional profiles were distinct, with SARS-CoV-2 seropositive children exhibiting a higher proportion of polyfunctional T cells compared to their seronegative counterparts. The frequency of SARS-CoV-2-specific CD4+ T cells in seronegative children was associated with the endemic human coronavirus (HCoV) HKU1 IgG response. Overall, the presence of SARS-CoV-2-responding T cells in seronegative children may result from cross-reactivity to endemic coronaviruses and could contribute to the relative protection from disease observed in SARS-CoV-2-infected children. Key words: SARS-CoV-2, Children, IgG responses, T cell response, Polyfunctional profile, endemic HCoV
    Keywords covid19
    Language English
    Publishing date 2023-05-23
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.05.16.23290059
    Database COVID19

    Kategorien

To top